Home

Kristen Ambrose, SVP & Chief Accounting Officer: Vertex Pharmaceuticals VRTX Sell · Filed 25/02/19

Trade details

Type
Insider sale
Amount
$305,345.26
Shares · price
671 sh · $455.06 a share
Held after
10,798 sh
Trade date
25/02/18
Filed
25/02/19
Days to filing
1 days

Sold 5.9% of holdings

Share of holding sold
5.9%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Kristen Ambrose's recent trades

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $172.6K

    Filed 03/02

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $108.5K

    Filed 02/26

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $762.1K

    Filed 02/19

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $302.2K

    Filed 02/19

  • Kristen Ambrose

    Sell10b5-1 planVertex Pharmaceuticals

    $633.6K

    Filed 02/12